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Available online 26 May 2016Background: Aging is associated with impaired ischemia-induced neovascularization. However, the effects of
aging on bone marrow-derived angiogenic cell (BMDAC)-mediated vasculogenesis and on angiogenesis at the
ischemic sites remain incompletely understood.
Methods and results: Two- and 24-month oldmale C57Bl/6Jmicewere subjected to hindlimb ischemia. The levels
of Sca1+/CXCR4+ BMDACs were determined post-ischemia by ﬂow cytometry. In young mice, ischemia in-
creased Sca1+/CXCR4+BMDAC levels in the bonemarrow and spleen at day 3 (p b 0.001) and in the circulating
blood at day 7 (p b 0.01) post-ischemia. However, ischemia-induced elevation of progenitor cellswas attenuated
in the bone marrow, spleen and blood of old mice despite a preserved HIF-1α-mediated angiogenic response in
the ischemic tissues. Irradiated young recipientmice engraftedwith old bonemarrowdisplayed reduced levels of
Sca1+/CXCR4+ BMDACs in the bonemarrow and circulating blood post-ischemia compared to recipients with
young bone marrow. Ex vivo cultured BMDACs from old mice exhibited reduced SDF-1-stimulated migration
(p b 0.01) and a decrease in JAK-2 and AKT activation. However, the intrinsic angiogenic function of BMDACs,
including VEGF secretion and promotion of endothelial cell tubule formation, was preservedwith aging. Further-
more, facilitatedmobilization of old bone marrow-derivedmononuclear cells to the ischemic hindlimb by intra-
muscular injection enhanced ischemia-induced neovascularization in old mice in vivo (p b 0.001).
Conclusions: The age-related impairment in ischemia-induced neovascularization is largely attributable to a
marked attenuation of BMDAC mobilization with a preservation of intrinsic angiogenic function with age.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Aging is an unavoidable biological deteriorative process that is asso-
ciated with a decline in adaptive responses toward different stressors,
including ischemia. Aging alone is a major risk factor for coronary and
peripheral artery disease and is also associatedwith increased incidence
of other cardiovascular diseases [1]. The majority of cardiovascular
disease-related deaths are in elderly individuals aged 75 years and
older. Cardiovascular disease in the elderly is hallmarked by impairment
in key vascular repair and regeneration processes including ischemia-
induced neovascularization [2–7]. With an increasingly aged globalte, 7 Eliza St., Newtown, 2042,
.
eliability and freedom from bias
land Ltd. This is an open access articlpopulation, there is a need to better understand the mechanisms of
age-related impairment in vascular repair in an attempt to provide
better therapies for elderly patients with vascular diseases.
Postnatal neovascularization is a key mechanism for cardiovascular
repair and regeneration following ischemia that relies on two interrelat-
ed processes: vasculogenesis and angiogenesis. Vasculogenesis involves
the proliferation and mobilization of angiogenic progenitor cells from
the bone marrow into the circulating blood [8–10]. Bone marrow-
derived angiogenic progenitor cells (BMDACs) consist of heterogeneous
cell populations which have been previously described as endothelial
progenitor cells, circulating angiogenic cells or proangiogenic myeloid
cells [11–13]. These progenitor cells with divergent angiogenic capabili-
ties have been shown to promote blood perfusion at the ischemic
sites by incorporating into newly formed blood vessels and/or promoting
vascular growth by producing angiogenic cytokines [14–15]. Angiogene-
sis is deﬁned as the formation of new blood vessels from the preexisting
ones. Ischemia-induced upregulation of a transcription factor hypoxia-
inducible factor-1α (HIF-1α) mediates the expression of angiogenesis-e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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stromal cell-derived factor-1 (SDF-1) [16–18]. HIF-1αmediated upregu-
lation of SDF-1 facilitates themobilization of progenitor cells into the cir-
culation through the binding to its receptor, C-X-C receptor 4 (CXCR4)
[19–21]. Upon binding of SDF-1 to its receptor CXCR4, janus kinase
(JAK) and phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathways
are activated to induce cell mobilization [22–24].
To date, the mechanisms underpinning the age-related decline in
ischemia-induced neovascularization remain incompletely understood.
The relative contribution of changes in the regenerative capacity of
circulating progenitor cells (“the seed”) versus changes in the pro-
regenerative environment in ischemic tissues (“the soil”) to the age-
related impairment in neovascularization remains debated. In this
study,we investigated the effect of agingon ischemia-inducedneovascu-
larization by using a murine hindlimb ischemia model involving young
and aged mice. We also examined the differential effects of aging on
the vasculogenic and angiogenic potential of BMDACs in vivo and in vitro.
2. Methods & materials
2.1. Mouse hindlimb ischemia (HLI) model
All animal studies were conducted with ethical approval from the
Sydney Local Health District Animal Ethics Committee (#2011-001A).
Two-month old male C57Bl/6J mice were purchased from Australian
BioResources and 24-month old male C57Bl/6J mice were purchased
from the National Institute of Aging (Bethesda, MD). Mice were housed
in a temperature-controlled environment with a 12 hour light and
12 hour dark cycle. Under inhalation of methoxyﬂurane, mice
underwent unilateral hindlimb ischemia (HLI) by femoral artery liga-
tion and excision [25]. A sham procedure was performed on the contra-
lateral limb. Adequate anesthesia was conﬁrmed throughout surgery by
testing the pedal reﬂex. Carprofen (5mg/kg)was used for analgesia, ad-
ministered subcutaneously following surgery. Mice were monitored
daily to determine the need of carprofen administration. Laser Doppler
perfusion imaging (LDPI) was performed prior to surgery, post-surgery
and at days 3, 5, 7, 10 and 14 post-ischemia (moorLDI2-IR, Moor Instru-
ments, UK). Blood ﬂowwas displayed as a heatmap, in which dark blue
indicatedminimal and red indicatedmaximumblood ﬂow. Blood perfu-
sion ratiowas expressed as the ratio of blood ﬂow in the ischemic vs. the
non-ischemic limb. Mice were euthanized at the indicated days for
experimental purposes.
2.2. Mononuclear cell (MNC) isolation
Upon sacriﬁce, femur and tibia were ﬂushed with phosphate-
buffered saline (PBS) to collect bone marrow. Spleens were homoge-
nized in PBS through a 70 μm nylon ﬁlter. Mononuclear cells (MNCs)
from the bone marrow, blood and spleen were isolated using
Lympholytes®-M Cell Separation Media (Cedarlane, Burlington,
Ontario). Total counts of mononuclear cells are included in Supplemen-
tary Table 1 in the online version at http://dx.doi.org/10.1016/j.ijcme.
2016.05.005. Cells were centrifuged at 740 ×g for 30 min. Buffy coats
were collected and washed twice with PBS + 10% fetal bovine serum
(FBS) (Sigma-Aldrich, St. Louis, MO). Cells were resuspended in EGM-
2 medium (Lonza, Basel, Switzerland) for ex vivo culture and ﬂow
cytometry analysis.
2.3. Bone marrow transplantation
Young recipient mice were irradiated once at 1000 rad dose prior to
bone marrow transplantation. Donor bone marrow cells (BMCs) were
ﬂushed from the femur and tibia of young and old mice with RPMI me-
dium (Sigma). Cell suspensions were ﬁltered with a 70 μm nylon mesh
and resuspended in the appropriate volume of RPMI for intravenous in-
jection (1 × 106 cells in 200 μl RPMI injected per recipient). Followingtransplantation, recipient mice were kept in a sterile environment for
6 weeks prior to any experimental surgery.
2.4. Intramuscular injection of MNCs
BonemarrowMNCs isolated from old donor mice were intramuscu-
larly injected in PBS into old mice immediately after HLI surgery
(1 × 106 MNCs per recipient). PBS alone was used in control animals.
Blood ﬂow recovery was monitored for 14 days post-ischemia using
LDPI.
2.5. Immunohistochemistry
Upon sacriﬁce, thigh adductor muscles were collected and embed-
ded in Tissue-Tek OCT compound (Finetek, New Taipei City, Taiwan).
Embedded tissue was snap-frozen in liquid nitrogen and stored at
−80 °C until use. Tissue cryosections (7 μm thick) were ﬁxed in
cold 3.7% paraformaldehyde for 10 min and rinsed with PBS. Capillary
density, arteriolar density and vessel sizes were examined by immuno-
staining with rat monoclonal anti-laminin (Abcam, Cambridge, UK),
rat monoclonal anti-CD31 conjugated to phycoerythrin (Abcam) and
mouse monoclonal α-smooth muscle actin conjugated to ﬂuorescein
isothiocyanate (FITC) (Sigma). Goat anti-rat IgG conjugated to
Alexaﬂuor 350 (Life Technologies, Grand Island, NY) was used as a sec-
ondary antibody. The capillary density (positive for CD31+) and arteri-
olar density (positive for α-smooth muscle actin) and vessel luminal
sizes were normalized to the numbers of myocytes.
2.6. Immunoﬂuorescence terminal deoxynucleotidyl transferase
dUTP nick-end labeling (TUNEL) staining
Apoptotic cells were determined by a DeadEND Fluorometric TUNEL
system (Promega), according to the manufacturer's protocol. Brieﬂy,
OCT-embedded tissues were ﬁxed with 4% paraformaldehyde for
15min andwashed twicewith PBS for 5min. After incubation in perme-
abilization solution for 10 min and washingwith PBS twice, tissue sam-
ples were incubated with TUNEL reaction mixture at 37 °C in humid
conditions for 1 h and encapsulated by mounting medium Vectashield
containing 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories,
Burlingame, CA). TUNEL-positive and DAPI-positive cells were counted
in ten randomly selectedmicroscopic ﬁelds. The percentages of apopto-
tic cells were expressed as TUNEL-positive cells per total number of
DAPI-positive cells.
2.7. Flow cytometry analysis
A subset of progenitor cells from bone marrow-derived angiogenic
cell (BMDAC) populations was identiﬁed as Sca1+/CXCR4+ BMDACs
by ﬂow cytometry using the hematopoietic stem cell marker Sca1 and
the SDF-1 receptor CXCR4, as previously described [26,27]. Isolated
bone marrow, spleen and blood MNCs were incubated with FcR
blocking solution (Miltenyi Biotec, Bergisch Gladbach, Cologne) accord-
ing to the manufacturer's protocol at 4 °C for 15 min. Cells were then
labelled with anti-mouse Sca1-V450 and anti-mouse CXCR4-APC (BD
Bioscience, San Jose, CA) at 4 °C for 30 min. Cells were then washed
twice with PBS + 10% FBS and resuspended in PBS + 2% FBS for ﬂow
cytometric analysis of Sca1+/CXCR4+ BMDACs (BDFACSVerse, Becton
Dickinson, Franklin Lakes, NJ).
2.8. Ex vivo culture of bone marrow-derived angiogenic cells (BMDACs)
BMDACswere cultured as previously described [28]. Brieﬂy, isolated
bonemarrowMNCswere plated on ﬁbronectin-coated 24-well plates at
2 × 106 cell density per well in EGM-2 + 10% FBS medium. Cells were
fed with fresh medium on alternate days. On day 5, cells were washed
with PBS and labelled with 3 μg/ml acetylated low density lipoprotein
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incubation, cells were labelledwith 2 μg/ml FITC-conjugated BS-1 lectin
from Ulex europaeus (Sigma) for 30 min at room temperature. Cells
were washed with PBS and replaced with fresh medium and imaged
with an Olympus IX71 microscope (Olympus Corporation, Tokyo,
Japan). The numbers of dil+/ulex+ cells were quantiﬁed in at least
10 images per well.2.9. In vitro migration assay
BMDACs (5000 cells/transwell)were plated onto the upper chamber
of 5 μmpore size 24-well transwells (Corning Inc., Corning, NY) in EBM-
2 + 2% FBS. EBM-2 + 2% FBS supplemented with 100 ng/ml mouse
recombinant SDF-1 (R&D Systems, Minneapolis, MN) was added to
the bottom chamber. BMDACs were allowed to migrate at 37 °C for
5 h. Transwells were removed and washed twice with PBS and ﬁxed
in ice-cold 70% ethanol for 30 min. Membranes were excised from the
transwells and placed on a glass slide. Slides were coverslipped with
Vectashield containing DAPI. To examine cellular signaling pathways
involved in BMDAC migration, cultured BMDACs were stimulated by
mouse recombinant SDF-1 (100 ng/ml) for 15 min prior to protein
extraction.2.10. BMDAC conditioned medium
BMDACs were cultured on a 6-well ﬁbronectin-coated plate
for 5 days in EGM-2 + 10% FBS. Medium was then replaced with
EBM-2 + 2% FBS for 24 h prior to collection. Conditioned media were
used to stimulate human umbilical vein endothelial cells (HUVECs) for
24 h prior to tubulogenesis assays. The VEGF levels in conditioned
media were quantiﬁed by VEGF ELISA.2.11. HUVEC tubulogenesis assay
HUVECs at 70% conﬂuency were washed with PBS and BMDAC con-
ditioned medium was added for 24 h prior to tubulogenesis assay as
previously described [29]. HUVECs were plated onto phenol red free,
growth factor reduced Matrigel (BD Bioscience) in a 96-well plate
(4000 cells/well) in quadruplicate wells and incubated at 37 °C for 6 h.
Cells were imaged at 20× magniﬁcation. Cell-to-cell branch points
were quantiﬁed using Image J software.2.12. Real-time quantitative PCR
Muscle tissuewas homogenizedwith TriReagent (Sigma). Total RNA
was extracted according to themanufacturer's protocol and 1 μg of RNA
was reverse transcribed using an iScript™ cDNA synthesis kit (Bio-Rad
Laboratories, Hercules, CA). Primer sequences used are as follows;
mouse HIF-1α, forward: 5′-TCCCTTGCTCTTTGTGGTTGGGT, reverse: 5′-
AACGTAAGCGCTGACCCAGG. Mouse Bcl-2, forward: CTCGTCGCTACCGT
CGTGACTTCG, reverse: CAGATGCCGGTTCAGGTACTCAGTC. Mouse Bax,
forward: AAGCTGAGCGAGTGTCTCCGGCG, reverse: GCCACAAAGATG
GTCACTGTCTGCC. Mouse 36B4 was used as internal control, forward:
5′-CAACGGCAGCATTTATAACCC, reverse: 5′-CCCATTGATGATGGAGTG
TGG (GeneWorks, SA, Australia). A CFX96 Touch™ Real-time PCR detec-
tion system was used to perform qPCR (Bio-Rad). PCR conditions were
as follows: 3 min at 95 °C; 30 s at 95 °C, 30 s at 60 °C and 30 s at 72 °C
(×40 cycles). Melt curve analysis was obtained from 55 °C to 95 °C
with a 0.5 °C increment for 10 min. Each run included negative reaction
controls. 36B4 was chosen as a housekeeping gene for normalization.
Expression levels were calculated by the relative quantiﬁcation method
(ΔΔCt). RT-qPCR was performed in triplicate for each sample.2.13. Protein isolation and Western blotting
Muscle tissue was homogenized with Mammalian Cell Lysis Buffer
(50 mM Tris–HCL, 1 mM EDTA, 150 mM sodium chloride, 0.1% sodium
dodecyl sulphate (SDS), 0.5% deoxycholic acid sodium salt solution,
1% IGEPAL, 1% protease inhibitor cocktail, 1% phosphatase inhibitor
cocktail) (Sigma). Protein concentration was determined by a standard
bicinchoninic acid assay (BCA) (Thermo Fisher Scientiﬁc, Rockford, IL).
Tissue protein (40 μg) or BMDAC protein (15 μg) was loaded onto
NuPAGE® Novex 4–12% Bis-Tris Gels (Life Technologies) and separated
using SDS-PAGE electrophoresis. Protein was transferred to
polyvinylidene ﬂuoride (PVDF) membranes using a semi-dry iBlot
gel transfer system (Life Technologies). Membrane was blocked with
1% skim milk in Tris-buffered saline (TBS) for 1 h at room temperature.
Primary antibodywas incubated at 4 °C overnight in 1% BSA at appropri-
ate dilutions for anti-HIF-1α, anti-pCXCR4 (S339), anti-CXCR4, anti-β-
actin, anti-tubulin (Abcam, Cambridge, UK), anti-pAkt, anti-Akt, anti-
pJak2, and anti-Jak2 (Cell Signaling Technologies, Danvers, MA).
Membrane was washed with 1× TBS–0.05% tween followed by incuba-
tionwith secondary antibodies conjugatedwith horseradish peroxidase
(HRP) for 2 h at room temperature in 1% skimmilk in TBS. Proteinswere
detected using Amersham enhanced chemiluminescence (ECL) reagent
(GE Healthcare Biosciences, Pittsburgh, PA).Western blot densitometry
was analyzed using Image Lab™ Software 4.0.1 (Bio-Rad).2.14. ELISA
SDF-1 levels in mousemuscle tissues were quantiﬁed using amouse
CXCL12/SDF-1 alpha Quantikine ELISA kit (R&D System) according to
manufacturer instructions. The concentrations of VEGF in BMDAC con-
dition media were quantiﬁed using a mouse VEGF Quantikine ELISA
kit (R&D System) according to manufacturer instructions.2.15. Statistical analysis
All data are expressed as mean ± SEM. Statistical analysis between
two groups was performed using unpaired Student's t-test. Statistical
analysis between more than two groups was performed using one-
way or two-way ANOVA with the Bonferroni post-test as indicated.
p b 0.05 was considered statistically signiﬁcant. All animal experiments
consisted of at least n = 5 mice.3. Results
3.1. Aging markedly impairs neovascularization following ischemia
To assess the effect of aging on ischemia-induced neovasculariza-
tion, young (2-month) and old (24-month) C57Bl/6Jmicewere subject-
ed to hindlimb ischemia (HLI). Blood ﬂow recovery was monitored by
Laser Doppler perfusion imaging (LDPI). Young mice began to recover
blood ﬂow after 3 days post-HLI and reached full recovery at 14 days.
By contrast, blood ﬂow recovery was strikingly attenuated in old mice
compared to young mice post-HLI (day 14; old: 0.094 ± 0.037 vs.
young: 0.939 ± 0.034; p b 0.001) (Fig. 1A). Histological analysis
revealed that the capillary density of the ischemic hindlimb was signif-
icantly reduced in old mice compared to youngmice at day 14 post-HLI
(old: 1.692 ± 0.091 vs. young: 2.010 ± 0.076; p b 0.05) (Fig. 1B). Arte-
riolar density (old: 0.057 ± 0.005 vs. young: 0.079 ± 0.010; p b 0.05)
and the vessel size (old: 15.76 ± 1.499 vs. young: 28.12 ± 2.481;
p b 0.001) were signiﬁcantly reduced in the old mice (Fig. 1C and D).
These results indicate that advanced aging impairs ischemia-induced
neovascularization, which is accompanied by reduced angiogenesis
and arteriogenesis.
Fig. 1. Ischemia-induced neovascularization in young and oldmice. Young (2-month) and old (24-month) C57Bl/6Jmice underwent hindlimb ischemia (HLI) surgery. Blood ﬂow recovery
wasmonitored by Laser Doppler perfusion imaging (LDPI). A) Representative images of LDPI of young and oldmice following hindlimb ischemia and quantiﬁcation of bloodperfusion ratio
in young and old mice after hindlimb ischemia. n = 8, data are presented as mean ± SEM. ***p b 0.001 vs. old. Two-way ANOVA with Bonferroni post-test. B) Representative images of
ischemicmuscles stained for CD31+ (red),α-smooth muscle actin (green) andmyocytes (blue) from young and old mice at day 14 post-HLI. Scale= 100 μm. Quantiﬁcation of capillary
density as number of CD31+ cells permyocyte. C)Quantiﬁcation of arteriolar density as number of vessels permyocyte. D)Quantiﬁcation of vessel size as the luminal areapermyocyte. At
least ﬁve micrograph images were quantiﬁed per mouse. n = 8, data are presented as mean ± SEM. *p b 0.05, ***p b 0.001. Unpaired t-test.
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mobilization
We investigated the effect of aging on BMDAC mobilization in
response to ischemia. By ﬂow cytometry analysis, we compared the
levels of BMDACs that co-expressed establishedmurine stem cell mark-
er Sca-1 and the SDF-1 receptor CXCR4 [26,27] in the mononuclear cell
populations of young and old mice. The levels of Sca1+/CXCR4+
BMDACs were signiﬁcantly increased in bone marrow of young mice
at day 3 post-HLI compared to pre-HLI (young; day 3: 1.970 ± 0.366
vs. pre-HLI: 0.6271 ± 0.078; p b 0.001) (Fig. 2A). A signiﬁcant increase
in the Sca1+/CXCR4+ BMDAC levels was observed in the spleen
of young mice at day 3-HLI (young; day 3: 17.010 ± 3.533 vs. pre-
HLI: 5.422 ± 1.266, p b 0.001) (Fig. 2B). Subsequently, the levels of
Sca1+/CXCR4+ BMDACs were signiﬁcantly increased in the circu-
lating blood at day 7 post-HLI compared to pre-HLI (young; day 7:
27.210 ± 3.162 vs. pre-HLI: 16.770 ± 1.530, p b 0.01) (Fig. 2C).
These data indicate that ischemia induces an increase in Sca1+/
CXCR4+ BMDAC levels in the bone marrow and the spleen, followed
by enhanced mobilization of Sca1+/CXCR4+ BMDACs into the cir-
culating blood of young mice.
Interestingly, the basal levels of bone marrow Sca1+/CXCR4+
BMDACs were signiﬁcantly higher in old mice compared to young
mice prior to induction of ischemia (pre-HLI; old: 3.212 ± 0.646 vs.
young: 0.6271 ± 0.078; p b 0.001). However, ischemia-induced prolif-
eration of Sca1+/CXCR4+ BMDACs in the bone marrow was absent
in old mice, with no signiﬁcant increase in the levels of Sca1+/
CXCR4+ BMDACs at day 3 post-HLI compared to pre-HLI (old; day 3:
3.972 ± 0.616 vs. pre-HLI: 3.212 ± 0.646; p = 0.439), indicating that
aging attenuated the proliferation of Sca1+/CXCR4+ BMDACs in the
bone marrow in response to ischemia (Fig. 2A). Moreover, unlike
young mice, there was no signiﬁcant increase in Sca1+/CXCR4+
BMDAC levels in the spleen of old mice at any day post-HLI. A slight,but insigniﬁcant, increase in the levels of Sca1+/CXCR4+ BMDACs
was observed in the circulating blood of the old mice at day 3 post-HLI
compared to pre-HLI (p = 0.173). By day 7, the circulating levels of
Sca1+/CXCR4+ BMDACs were not increased by ischemia in the old
mice, which displayed signiﬁcantly lower Sca1+/CXCR4 BMDAC levels
in the blood compared to young mice on day 7 post-ischemia (day 7;
old: 17.130 ± 1.089 vs. young: 27.210 ± 3.162; p b 0.05) (Fig. 2C).
Taken together, the results indicate that despite having adequate basal
levels of bone marrow Sca1+/CXCR4+ BMDACs, aging attenuates
ischemia-induced proliferation of Sca1+/CXCR4+ BMDACs in the
bone marrow and accumulation in spleen as well as the mobilization
of Sca1+/CXCR4+ BMDACs into the circulating blood.
3.3. Hypoxia-induced expression of HIF-1α in ischemic tissue is maintained
with aging
HIF-1α is a transcription factor which plays a critical role in mediat-
ing the adaptive tissue responses to ischemia by regulating the expres-
sion of hundreds of genes including those of key angiogenic cytokines
such as VEGF and SDF-1 [16,18]. The mRNA and protein expression
levels of HIF-1α in the hindlimb adductor muscle from young and old
mice were examined at day 3 post-HLI. Induction of ischemia was asso-
ciated with a signiﬁcant increase in HIF-1αmRNA levels in young mice
(1.958 ± 0.118-fold increase vs. non-ischemic; p b 0.001) (Fig. 3A),
which was associated with increased HIF-1α protein levels at day 3
post-HLI (2.526 ± 0.458-fold increase vs. non-ischemic; p b 0.01)
(Fig. 3B). By contrast, ischemia-induced upregulation of HIF-1αmRNA
was not observed in the tissue of old mice (Fig. 3A). Nevertheless, HIF-
1α protein increased signiﬁcantly in the ischemic tissue compared to
the non-ischemic tissue of old mice at day 3 (2.457 ± 0.169-fold in-
crease vs. non ischemic; p b 0.05). The increased level of HIF-1α protein
in oldmicewas comparable to that of the ischemic tissue of youngmice
(Fig. 3B). Consistentwith regulation of SDF-1 expression byHIF-1α [17],
Fig. 2. Sca1+/CXCR4+ BMDAC levels in young and old mice post-ischemia. Flow
cytometry analysis of the percentage of Sca1+/CXCR4+ BMDACs in total mononuclear
cell (MNC) populations from A) bone marrow, B) spleen, and C) blood of young and old
mice following ischemia. n = 8, data are presented as mean ± SEM. ###p b 0.001,
##p b 0.01 vs. young pre-HLI. One-way ANOVA with Dunnett post-test. ***p b 0.001,
*p b 0.05 vs. young. Two-way ANOVA with Bonferroni post-test.
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to non-ischemic tissue in both young (ischemic: 4.668± 1.564 vs. non-
ischemic: 1.00 ± 0.052, p b 0.05) and old (ischemic: 6.370 ± 0.993 vs.
non-ischemic 2.180 ± 0.397, relative to young non-ischemic,
p b 0.005) mice at day 3 at comparable levels (Fig. 3C).
Given that an early ischemic induction of HIF-1α protein was ob-
served in old mice, we next examined HIF-1α expression levels at alater stage of ischemia. Seven days after induction of ischemia, HIF-1α
mRNA and protein levels were higher in the ischemic tissues compared
to the non-ischemic tissues in youngmice, but this was no longer statis-
tically signiﬁcant. While ischemia-induced HIF-1αmRNA upregulation
remained absent in old mice (Fig. 3D), HIF-1α protein expression was
signiﬁcantly higher in the ischemic tissues compared to the non-
ischemic limb in old mice (ischemic: 4.047 ± 0.398 vs. non-ischemic:
2.372 ± 0.310 relative to young non-ischemic; p b 0.01) (Fig. 3E). By
day 7, ischemia-induced SDF-1 levels had declined in both young and
old mice without any signiﬁcant difference (Fig. 3F).3.4. Intrinsic impairment of ischemia-induced proliferation and
mobilization of Sca1+/CXCR4+ BMDACs with aging
Given that ischemia induces comparable augmentation of SDF-1
expression in young and old mice, but reduced circulating Sca1+/
CXCR4+ BMDACs in old mice, we next investigated whether themobi-
lization of Sca1+/CXCR4+ BMDACs is intrinsically impaired with age,
independent of tissue cytokines. Bone marrow from either young or
old mice was transplanted into young recipients. After 6 weeks of
bone marrow engraftment, young recipient mice were subjected to
hindlimb ischemia (HLI). The levels of Sca1+/CXCR4+ BMDACs in
the bone marrow, spleen and blood were examined.
Bone marrow Sca1+/CXCR4+ BMDAC levels were signiﬁcantly in-
creased in young recipients with young bone marrow (BM) at day 3
and day 7 post-HLI compared to pre-HLI (young BM; day 3: 2.200 ±
0.094 and day 7: 2.448 ± 0.134 vs. pre-HLI: 1.130 ± 0.202; p b 0.001)
(Fig. 4A). In contrast, ischemia-induced proliferation of bone marrow
Sca1+/CXCR4+ BMDACs was completely abolished in young mice
receiving old bone marrow, and no signiﬁcant increase in Sca1+/
CXCR4+ BMDACs was observed at any day post-HLI. The levels of
Sca1+/CXCR4+ BMDACs were signiﬁcantly lower in recipients of
old bone marrow compared to those with young bone marrow at
day 3 and day 7 post-HLI (day 3; old BM: 1.312 ± 0.069 vs. young BM:
2.200 ± 0.094, p b 0.001; day 7; old BM: 1.460 ± 0.171 vs. young BM:
2.448 ± 0.134, p b 0.001) (Fig. 4A). Interestingly, comparable levels
of Sca1+/CXCR4+ BMDACs were found in the spleen of recipients
that received young or old bone marrow (Fig. 4B). The circulating
Sca1+/CXCR4+ BMDAC levels were comparably elevated in the
blood of young recipient mice transplanted with either young or old
bone marrow at day 3 post-HLI compared to pre-HLI (young BM; day
3: 20.460 ± 3.271 vs. pre-HLI: 5.158 ± 1.535; p b 0.001, old BM; day
3: 23.160±2.806 vs. pre-HLI: 4.044±0.981; p b 0.001) (Fig. 4C). Circu-
lating Sca1+/CXCR4+ BMDAC levels remained signiﬁcantly increased
at day 7 in recipients with young bone marrow compared to pre-HLI
(young BM; day 7: 30.790 ± 1.986 vs. pre-HLI: 5.158 ± 1.535;
p b 0.001). However, the ischemia-induced BMDAC mobilization to
blood was less robust and less sustained in recipients of old marrow
by day 7 post-HLI. The circulating levels of Sca1+/CXCR4+ progenitor
cells were signiﬁcantly reduced to less than a third in recipients of old
bone marrow compared to those with young bone marrow (day 7; old
BM: 8.922 ± 0.849 vs. young BM: 30.790 ± 1.986; p b 0.001)
(Fig. 4C). To determine whether ischemia-induced tissue response in
recipient mice with old bone marrow differs from those transplanted
with young bone marrow, SDF-1 levels in muscle tissues were
examined. The levels of SDF-1 in muscle tissues were similar between
recipient mice transplanted either young or old bone marrow at day 3
post-HLI. A decline in SDF-1 levels was observed in all recipients
by day 7 post-HLI (Supplementary Fig. 1 in the online version at
http://dx.doi.org/10.1016/j.ijcme.2016.05.005.). These results demon-
strate that ischemia-induced proliferation of Sca1+/CXCR4+ progeni-
tor cells in the bone marrow is intrinsically impaired with age and
that the mobilization of progenitor cells from aged donors is less
sustainable for a prolonged period post-ischemia, despite an equivalent
ischemic environment in the young recipients.
Fig. 3. Ischemia-induced tissue response in young and oldmice. The levels of HIF-1α and SDF-1 inmuscle tissues from young and oldmicewere examined at day 3 (A–C) and day 7 (D–F)
post-ischemia. A and D) The mRNA levels of HIF-1α were examined by real-time qPCR. B and E) HIF-1α protein levels were examined by Western blotting. C and F) SDF-1 levels were
examined by ELISA. Data are normalized to young non-ischemic control. n = 8. ###p b 0.001, ##p b 0.01, #p b 0.05 vs. young non-ischemic, **p b 0.01, *p b 0.05 vs. old non-ischemic.
Two-way ANOVA with Bonferroni post-test. ns, not signiﬁcant.
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angiogenic capacity of BMDACs is retained with aging
To evaluate in more detail the effects of aging on BMDAC function,
we studied ex vivo cultured BMDACs from bone marrowMNCs capable
of Dil-AcLDL and lectin uptake [28]. BMDACs from young and old mice
at day 3 post-HLI were ex vivo cultured at equivalent densities. The
levels of dil+/ulex+ BMDACs from old mice were signiﬁcantly lower
than that from young mice (old: 779.0 ± 156.6 vs. young: 2707.0 ±
247.3; p b 0.001) (Fig. 5A). Furthermore, BMDACs from old mice exhib-
ited a 58% reduction of SDF-1-stimulated migratory function compared
to those from young mice (old: 51.67 ± 6.642 vs. young: 123.80 ±
19.46; **p b 0.01) (Fig. 5B).Western blot analysis showed that the levels
of CXCR4 phosphorylationwere similar in BMDACs from young and old
mice after SDF-1 stimulation (Fig. 5C). However, BMDACs from oldmice
displayed a modest reduction of JAK-2 phosphorylation and a marked
increase in total JAK-2 protein levels (Fig. 5D). AKT phosphorylation
was also signiﬁcantly reduced in BMDACs from old mice (Fig. 5E). The
results indicate that age-related impairment in BMDAC migration
could be, partly, associatedwith decreased JAK-2 and AKT phosphoryla-
tion, downstream of CXCR4 signaling pathway.
We next investigated whether old BMDACs retain the capacity to
augment angiogenesis in vitro. Vascular endothelial growth factor
(VEGF) secretion by BMDACs and the capacity for BMDAC conditioned
media to stimulate human umbilical vein endothelial cell (HUVEC) tu-
bule formation were examined. VEGF secretion by old and young
BMDACs was not signiﬁcantly different (old: 2.304 ± 0.326 vs. young:
2.991 ± 1.170 pg/μg; p = 0.647) (Fig. 5F). HUVECs were cultured ineither old or young BMDAC conditioned media for 24 h prior to
tubulogenesis assay. The numbers of tubule branch points formed
by HUVECs cultured in conditioned media from old BMDACs were
comparable to those cultured in conditioned media from young
BMDACs (old: 47.33 ± 2.804 vs. young: 54.06 ± 3.718) (Fig. 5G).
These results indicate that BMDACs retain paracrine angiogenic func-
tion with age through the secretion of VEGF which promotes and
induces tubule formation in endothelial cells.
3.6. Old MNCs retained capacity to enhance neovascularization in vivo if
mobilized
Having demonstrated that aging is associated with impairment in
BMDAC migratory function but preservation of angiogenic capacity,
we next determined whether facilitated mobilization of old BMDACs
could enhance ischemia-induced neovascularization in old mice. Bone
marrowMNCs from oldmicewere intramuscularly injected into the ad-
ductor muscle of old recipients following HLI. Mice that received MNCs
demonstrated signiﬁcant improvement in blood ﬂow recovery com-
pared to mice which received PBS (day 10; old MNCs: 0.642 ± 0.119
vs. PBS: 0.385±0.072; p b 0.001) (Fig. 6A). Histological analysis showed
that capillary density was signiﬁcantly higher in mice which received
MNCs compared to PBS (old MNCs: 1.844 ± 0.124 vs. PBS: 1.164 ±
0.071; p b 0.001) (Fig. 6B). Arteriolar density and vessel size were also
increased in mice which received MNCs compared to PBS (arteriolar
density; old MNCs: 0.046 ± 0.004 vs. PBS: 0.028 ± 0.002, p b 0.001.
Vessel size; old MNCs: 26.86 ± 1.345 vs. PBS: 21.87 ± 1.224, p b 0.05)
(Fig. 6C and D). To examine whether the presence of old MNCs
Fig. 4. Sca1+/CXCR4+ BMDAC levels in young recipients transplanted with young or old
bone marrow following ischemia. Bone marrow (BM) from young or old mice was
transplanted into irradiated young recipients which then received HLI surgery. The
levels of Sca1+/CXCR4+ BMDACs were quantiﬁed with ﬂow cytometry in the A) bone
marrow, B) spleen, and C) blood post-HLI. n = 5, data are presented as mean ± SEM.
###p b 0.001, ##p b 0.01 vs. young BM pre-HLI. ^^^, p b 0.01 vs. old BM pre-HLI. One-
way ANOVA with Dunnett post-test. ***p b 0.001 vs. young BM. Two-way ANOVA with
Bonferroni post-test.
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examined in the tissues of old mice. By day 14, the levels of SDF-1
were higher in the muscle tissues of old mice received old MNCs com-
pared to PBS injection, albeit not signiﬁcant (Supplementary Fig. 2 in
the online version at http://dx.doi.org/10.1016/j.ijcme.2016.05.005.).
Ischemia induces apoptosis and the expression of apoptosis-related
genes is associated with tissue salvage [30]. ImmunoﬂuorescenceTUNEL staining of the ischemic tissue showed that the ratio of TUNEL-
positive cells in old mice received old MNCs was signiﬁcantly lower
than PBS control (old MNCs: 0.007 ± 0.002 vs. PBS: 0.051 ± 0.015,
p b 0.01). Next, apoptosis-related gene expressions were examined.
Bcl-2 inhibits apoptosis by forming a heterodimer with pro-apoptotic
Bax protein [31]. ThemRNA expression of Bcl-2 was signiﬁcantly higher
in ischemic tissues of old mice received MNCs compared to that in PBS
control (old MNCs: 1.881 ± 0.305 vs. PBS: 0.598 ± 0.278, p b 0.05).
Meanwhile, the expression of Bax was signiﬁcantly lower in ischemic
tissues of old mice received MNCs compared to that in PBS control
(old MNCs: 0.814 ± 0.269 vs. PBS: 1.664 ± 0.274, p b 0.05). The results
indicate that old bone marrow MNCs retain adequate pro-angiogenic
function and that facilitated cell mobilization by intramuscular injection
promotes neovascularization and improves tissue salvage in old mice
post-ischemia.
4. Discussion
There is an age-related impairment in ischemia-mediated neovascu-
larization [2,6,7,12,32], the mechanisms of which are incompletely
understood. The salient ﬁndings of this study are that: i) aging attenu-
ates the proliferation and accumulation of Sca1+/CXCR4+ bone
marrow-derived angiogenic cells (BMDACs) in bonemarrowand spleen
following ischemia; ii) aging impairs the intrinsic capacity of BMDACs to
mobilize to the circulating blood in response to ischemia; iii) the adap-
tive responses of ischemic tissue are, at least in part, preserved in old
mice with comparable induction of HIF-1α and SDF-1 expression
relative to young mice; iv) despite age-related impairment in
ischemia-induced proliferation andmigration, BMDACs retain paracrine
angiogenic function; and v) facilitated mobilization of old BMDACs
enhances ischemia induced neovascularization in aged animals. These
ﬁndings identify a critical role for loss proliferative andmigratory capac-
ity of BMDACs in the age-related impairment in ischemia-induced
neovascularization. Given that the angiogenic potential of mobilized
BMDACs is preserved with age, therapeutic strategies that enhance
the efﬁcacy of mobilizing BMDACs could improve clinical outcomes in
elderly patients with vascular diseases.
Aging is associated with a severe impairment in ischemia-mediated
neovascularization. However, whether this age-related impairment is
due to a decline in the regenerative capacity of bone marrow-derived
progenitor cells and/or a decline in the pro-regenerative environment
in the ischemic tissues remains debated. It has been proposed that an
age-dependent exhaustion of progenitor cells underpins the impair-
ment in vascular repair in older animals [4]. In the present study, we
demonstrate that the basal Sca1+/CXCR4+ progenitor cell levels in
the bonemarrow are not attenuated with age. In linewith other studies
[33,34], age-dependent depletion of progenitor cells is likely to be spe-
ciﬁc to a subpopulation of intermediate vascular progenitor cells
(CD31+/CD45−) whereas the primitive progenitor subpopulations
(Sca1+/c-kit+/lin−) are not affected by age. In fact, higher basal levels
of bone marrow Sca1+/CXCR4+ BMDACs were found in aged mice
prior to ischemia. It has been reported that hematopoietic stem cell ex-
pansion is associated with aging. The levels of CD34−/c-kit+/Sca1+
stem cell increase 17-fold from 2 to 18 months of age in C57Bl/6J mice
with constant levels of bone marrow cells [35]. However, it is accompa-
nied by reduction in self-renewal and lymphoid differentiation
potentials [35–39]. Consistently, despite having adequate bonemarrow
Sca1+/CXCR4+ BMDACs at basal levels, ischemia-induced BMDAC
proliferation is attenuated in old mice. In youngmice, ischemia induces
accumulation of Sca1+/CXCR4+ BMDACs in the spleen followed by
BMDAC mobilization into the circulation. The spleen is a transient
reservoir for progenitor cell trafﬁcking [40]. It has been demonstrated
that approximately 70% of endothelial progenitor cells home to the
spleen following intravenous injection [41]. The spleen may also serve
as an additional source of progenitor cell production. In mice, mononu-
clear cells isolated from spleen homogenates can differentiate into
Fig. 5. Angiogenic function of ex vivo cultured BMDACs. BMDACs were ex vivo cultured from bone marrow-derived MNCs from young and old mice. A) The numbers of dil+/ulex+ cells
from young and old mice at day 3 post-ischemia after 5 days in culture. Right, representative images from young (top) and old (bottom) mice. Scale = 100 μm. n = 5, ***p b 0.001.
Unpaired t-test. B) Quantiﬁcation of SDF-1-stimulated BMDAC migration. Right, representative images of DAPI-stained, migrated BMDACs. Scale = 100 μm. n = 3, **p b 0.01. Unpaired
t-test. Western blot analysis of the phosphorylation levels of C) CXCR4, D) JAK-2 and E) AKT of ex vivo cultured BMDACs from young and old mice after 15 min exposure to 100 ng/ml
SDF-1. Data are normalized to young BMDACs. n = 3. ***p b 0.001, **p b 0.01. F) The secreted level of VEGF in BMDAC conditioned media measured by ELISA. Normalized to total
protein (pg/μg). G) HUVECs were cultured in conditioned media from young and old BMDACs for 24 h prior to tubulogenesis assay. Quantiﬁcation of tubule branches per 4000
HUVECs. n = 3. Unpaired t-test.
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contributing, at least partly, to a portion of the circulating progenitor
cell population. In marked contrast to young mice, the accumulation
of Sca1+/CXCR4+ BMDACs is abolished in the spleen of old mice
post-ischemia. Furthermore, aging is associated with a loss of progeni-
tor cell mobilization into the circulation in response to ischemia, with
circulating Sca1+/CXCR4+ BMDAC levels post-ischemia being not
signiﬁcantly different to the basal pre-ischemic levels in the blood of
old mice. The dynamics of ischemia-induced progenitor cell mobiliza-
tion is markedly impaired with aging.
It has been suggested that the decrease in progenitor cell mobiliza-
tion with aging is due to an age-related impairment of HIF-1α,
highlighting an aging effect on the pro-regenerative environment in
ischemic tissues [12,33]. The current study, however, shows that
ischemia induces similar levels of HIF-1α and SDF-1 in old mice com-
pared to those found in young mice at day 3 post-ischemia. In compar-
ison to the hindlimb ischemia model used in this study, Chang et al.
demonstrated an attenuation of HIF-1α expression in aged mice using
a murine skin ﬂap model [33]. This discrepancy may reﬂect inherent
differences between skin and muscle tissues and suggests that tissue
differences may exist in terms of the effect of aging on repair mecha-
nisms. Although the expression levels of HIF-1α in skin and skeletal
muscle tissues have not been directly compared under ischemic condi-
tions, Chen et al. has demonstrated that murine dorsal skin wounds are
signiﬁcantly more hypoxic and exhibit higher levels of HIF-1α
compared to oral mucosal wounds under basal and stressed conditions
[44]. It is likely that regulation of HIF-1α is tissue-speciﬁc and isdifferentially expressed depending on oxygen sensitivity andmetabolic
requirements. Therefore, the disparity of aging effects on the ischemia-
mediated HIF-1α upregulation could be, partly, explained by the use of
different murine models with our current ﬁndings being more directly
relevant to the effects of aging on the regenerative response to vascular
occlusion.
Interestingly, we found that old mice display a prolonged elevation
of HIF-1α expression in both non-ischemic and ischemic tissues while
the ischemia-induced HIF-1α expression returns to basal level in
young mice after 7 days of ischemia. This may indicate an age-related
loss of HIF-1α regulation where the elevated HIF-1α fails to return to
the basal level after ischemia. The prolonged elevation of HIF-1α could
be disadvantageous and detrimental. For example, a transgenic mouse
model with a constitutive HIF-1α expression develops cardiomyopathy
with age as a result of high energy demand in the heart. In parallel,
patients with end-stage heart failure are found to have an increased
stabilization of HIF-1α in the heart [45]. Together with the current ﬁnd-
ings, this suggests that aging may be associated with a loss of HIF-1α
regulation in response to stress stimuli.
Having identiﬁed an age-related impairment in vasculogenesis
characterized by failure in ischemia-induced progenitor cell prolifera-
tion and mobilization, we used bone marrow transplantation experi-
ments to further characterize the role of aged-related changes in
the intrinsic function of BMDACs. These experiments showed
that ischemia-induced proliferation of Sca1+/CXCR4+ BMDACs is
abolished in young recipients of old bone marrow. Furthermore, recipi-
ents of old marrow exhibit a less robust and less sustainedmobilization
Fig. 6. Facilitated mobilization of old MNCs in old mice. Old mice received an intramuscular injection of bone marrow MNCs isolated from old mice or PBS alone following HLI surgery.
A) Representative images of LDPI of old mice received PBS or old MNCs at the indicated days post-HLI. Blood perfusion ratio of blood ﬂow recovery. n = 5, data are presented as
mean ± SEM. ***p b 0.001, **p b 0.01 vs. PBS injection. Two-way ANOVA with Bonferroni post-test. B) Representative images of ischemic muscle tissues stained for CD31+ (red), α-
smooth muscle actin (green) and myocytes (blue) from old mice received PBS or old MNCs intramuscular injection at 14 days post-HLI. Quantiﬁcation of capillary density as number
of CD31+ cells per myocyte. C) Quantiﬁcation of arteriolar density as number of vessels per myocyte. D) Quantiﬁcation of vessel size as the luminal area per myocyte. At least ﬁve
micrograph images were quantiﬁed per mouse. n = 5, data are presented as mean ± SEM. *p b 0.05, ***p b 0.001. Unpaired t-test. E) TUNEL staining of ischemic tissues of old mice
received PBS or old MNCs at day 14. Data are presented as the mean ratio of the numbers of TUNEL-positive cells per total numbers of DAPI-positive cells. At least ten micrograph
images were quantiﬁed per mouse. Scale = 100 μm. n = 5, data are presented as mean ± SEM. **p b 0.01. Unpaired t-test. The levels of F) Bcl-2 and G) Bax mRNA expressions in the
non-ischemic and ischemic tissues. Data are normalized to PBS non-ischemic control. n = 5. *p b 0.05 vs. PBS ischemic tissues. Two-way ANOVA with Bonferroni post-test.
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ﬁndings demonstrate that transplantation of old bone marrow into
a youthful host tissue environment could not restore the vasculogenic
response to ischemia, consistent with an intrinsic age-related BMDAC
dysfunction. Interestingly, the levels of Sca1+/CXCR4+ BMDAC in the
spleen are independent of donor age. By transplanting GFP+ donor
cells into GFP− recipient mice, Filip et al. reported that N40% of the
recipient's own cells remained in the spleen after the bone marrow
transplantation, while b20% of the recipient's cells are found in the
bone marrow and circulating blood [46]. The chimerism in the spleen
may explain the similar levels of Sca1+/CXCR4+ progenitor cells
found in recipients with either young or old bone marrow.
We used in vitro assays of cultured BMDACs to further characterize
the effects of aging on progenitor cell function. Consistent with our
in vivo ﬁndings, ex vivo cultured BMDACs from old mice are impaired
with respect to migratory and proliferative function. In contrast, we
found that old BMDACs retain VEGF secretory function and the capacityto induce angiogenesis by paracrinemechanisms. Similarly, Williamson
et al. reported that outgrowth endothelial progenitor cells (OECs) de-
rived from the peripheral blood of elderly aged 50–70 years display a
functional impairment in SDF1-stimulated migration with preserved
tube-forming ability [47]. Together, this suggests that the angiogenic
functions of BMDACs are differentially affected by age.
Cell migration is mediated by SDF-1 binding to its receptor CXCR4,
which is associated with the activation of JAK and AKT signaling
[22–24]. In this study, we show that the phosphorylation levels of
JAK-2 and AKT aremarkedly reduced in BMDACs from oldmice, indicat-
ing a possible link between impaired cell migration and age-related
alteration in cell signaling pathways. Consistent with this, JAK-2 phos-
phorylation is decreased in the hippocampus of short-lived klotho
mutant mice [48]. A reduction in JAK-2 phosphorylation has also been
reported in progenitor cells isolated from the peripheral blood of
elderly, which is associated with decreased cell migration and adhesion
in vitro [49]. On the other hand, age-related reduction in AKT
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tissues, suggesting that it may be a general impairment in response to
various stimuli with age.
We further demonstrated that the angiogenic capacity in old
BMDACs remains functional in vivo. Bone marrow MNCs from old
mice retain sufﬁcient angiogenic potential to promote angiogenesis
and arteriogenesis when cells are intramuscularly injected to the
ischemic tissues of old mice. In addition, the presence of old MNCs
improves tissue salvage by reducing apoptotic levels in the ischemic
tissues of oldmice. Direct cell administration by intramuscular injection
to the ischemic tissues bypasses the need of progenitor cells to exit from
the bonemarrow andmobilize into the circulation, aswell asminimizes
cell retention in organs, such as the spleen and liver. This ﬁnding
recapitulates the success of clinical studies involving autologous bone
marrow MNC implantation [50–53]. Interestingly, saline injection
slightly increased the blood ﬂow in old mice post-ischemia, which
may be explained by the vasodilatory effect generated by the injection
[54]. However, there are some limitations. Although it is expected that
Sca1+/CXCR4+ BMDACs are present in the bone marrow MNCs, we
could not exclude the possibility that other subpopulations of angiogen-
ic progenitor cells facilitate the blood ﬂow recovery in the old mice
following ischemia. The limited amount of Sca1+/CXCR4+ BMDACs
present in the bone marrow poses a difﬁculty in harvesting sufﬁcient
quantity for injection. Cell isolation by FACS or magnetic bead sorting
may affect cell viability and damage the intrinsic angiogenic potential
of Sca1+/CXCR4+ BMDACs from old mice.
In conclusion, age-related impairment in neovascularization is
attributable to a decline in ischemia-induced bone marrow-derived
angiogenic cell proliferation and mobilization to the circulating blood
with a partial preservation of HIF-1α-mediated tissue angiogenic re-
sponse with age. Furthermore, our ﬁndings suggest that the intrinsic
functions of BMDACs are differentially affected by agewith preservation
of paracrine-mediated angiogenic function, but impairment in migrato-
ry capacity. This study provides further understanding to the mecha-
nisms involved in age-related impairment in ischemia-induced
neovascularization. Strategies that enhance the vasculogenic response
in elderly patients by promoting progenitor cell proliferation andmobi-
lization may have potential to enhance clinical outcomes in patients
suffering ischemic manifestations of athero-occlusive disease.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijcme.2016.05.005.
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